𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunogenicity of wild and attenuated varicella-zoster virus strains in rhesus monkeys

✍ Scribed by Yoshizo Asano; Paul Albrecht; Dorothy E. Behr; Beverly J. Neff; James H. Vickers; Suresh C. Rastogi


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
508 KB
Volume
14
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Thirty susceptible rhesus monkeys were inoculated with cell-free varicella-zoster virus strain OKA or strain KMcC. Both wild and attenuated strains were used. No clinical signs characteristic of human varicella were seen in any of the animals. Virus was not isolated from throat swabs, blood, or cerebrospinal fluid. Antibodies were measured by an enhanced plaque neutralization test. The wild and attenuated OKA strains produced comparable levels of antibodies for 3 months after inoculation. Attenuated KMcC strains produced lower titers than the wild strain. On rechallenge 3 months after primary inoculation animals boostered with the attenuated OKA strain developed significantly higher antibody titers than animals receiving the wild strain. Animals primed and challenged with the attenuated KMcC strains showed significantly lower antibody titers than animals which received the wild strain. The results indicate that the immunogenicity of attenuated OKA and KMcC strains in rhesus monkeys parallels the experience obtained with these strains in humans.


πŸ“œ SIMILAR VOLUMES


Genotypes of varicella-zoster virus wild
✍ A. Sauerbrei; R. Zell; A. Philipps; P. Wutzler πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 335 KB

## Abstract Surveillance of varicella‐zoster virus (VZV) genotypes is indicated in Germany after implementation of universal varicella vaccination. This article reports genotyping data of 77 VZV strains obtained from 54 patients with varicella, 1 newborn with congenital varicella syndrome, 2 fetuse

Differentiation of Oka varicella vaccine
✍ Dr. Kimiyasu Shiraki; Kiyoshi Horiuchi; Yoshizo Asano; Koichi Yamanishi; Dr. Mic πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 936 KB

The Oka varicella vaccine strain can be differentiated from wild-type strains by its unique restriction endonuclease fingerprinting (REFP: HpaI-K and EcoRI-P) pattern of the gpV-coding region of the varicella-zoster virus (VZV) genome. VZV-DNAs from patients with complicated clinical courses related

An evaluation of single nucleotide polym
✍ Mark Quinlivan; Anne A. Gershon; Sharon P. Steinberg; Judith Breuer πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 260 KB

## Abstract Rashes following immunization with the vaccine strain (vOka) of varicella‐zoster virus (VZV) may occur in up to 5% of children and 10% of adults. In 40% of cases, the causative virus is the vaccine strain and in 60% wild type virus is found. Several reports have identified three restric

Analysis of United Kingdom wild-type str
✍ Hawrami, K.; Breuer, J. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 47 KB

In Japan and the United States, where vaccination against varicella-zoster virus (VZV) infection with the live attenuated Oka strain of varicella is routine, cases of chickenpox or shingles occurring in vaccinees can be caused by either wildtype or vaccine virus. Differentiating such cases is import

Molecular characterisation of varicella-
✍ A. Sauerbrei; U. Eichhorn; S. Gawellek; R. Egerer; M. Schacke; P. Wutzler πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 141 KB

## Abstract With the introduction of varicella vaccination, surveillance of varicella‐zoster virus (VZV) strains occurring in cases of chickenpox or zoster should be considered. Differentiating Oka vaccine strain from wild‐type VZV can be achieved only using molecular genotyping. In the present stu

Hepatitis a virus: Growth characteristic
✍ Daniel W. Bradley; Charles A. Schable; Karen A. McCaustland; E. H. Cook; Bert L. πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 870 KB

Serial passage of the MS-1 strain hepatitis A virus (HAV) in marmosets was shown to increase the yield of virus and to shorten the incubation period from approximately 55 days in the first passage to 3-7 days in the ninth and higher passages. Intravenous inoculation of susceptible chimpanzees with M